Unconventional Bladder Preservation: Factors Predicting Failure to Receive Definitive Surgery following Chemotherapy for Nonmetastatic Muscle Invasive Bladder Cancer in the National Cancer Database

被引:4
作者
Kapadia, Akash A. [1 ]
Acevedo, Ann Martinez [1 ]
Liu, Jen-Jane [1 ]
Garzotto, Mark [1 ]
Conlin, Michael [1 ]
Amling, Christopher [1 ]
Kopp, Ryan P. [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Urol, 3303 South West Bond Ave,Mail Code CH10U, Portland, OR 97939 USA
关键词
urinary bladder neoplasms; neoplasm invasiveness; drug therapy; cystectomy; delivery of health care; RADICAL CYSTECTOMY; NEOADJUVANT CHEMOTHERAPY; CARE TRANSITIONS; SURVIVAL; MORTALITY; THERAPY; DELAY;
D O I
10.1016/j.juro.2018.03.075
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Neoadjuvant chemotherapy is an important adjunct to cystectomy for managing muscle invasive bladder cancer. Using the National Cancer Database we investigated factors that predict failure to undergo surgery following multi-agent chemotherapy for nonmetastatic muscle invasive bladder cancer. Materials and Methods: We performed a cohort study in patients diagnosed with cT2-4aN0M0 urothelial cell carcinoma of the bladder between 2004 and 2013 who underwent multi-agent chemotherapy. We excluded those with surgery prior to chemotherapy, clinical T4b disease and those who received radiotherapy. Socioeconomic and clinical predictors, including time from diagnosis to treatment, were analyzed using logistic regression for the receipt of surgery after chemotherapy. Cox proportional hazards modeling was applied to perform time dependent analysis. Results: Of the 4,640 patients who met our study inclusion and exclusion criteria 4,244 (91%) proceeded to surgery. Negative predictors of surgery included African American or Hispanic race (OR 0.58, p = 0.007 and 0.48, p = 0.002, respectively), increasing age (OR 0.44, p < 0.001) and greater time between diagnosis and chemotherapy initiation (fourth quartile greater than 59 days, OR 0.51, p < 0.001). African American race (HR 0.79, p < 0.001), Medicare (HR 0.86, p < 0.001) and other government insurance (HR 0.73, p < 0.001) were associated with delayed chemotherapy. Conclusions: Increasing age, African American or Hispanic race and longer time to chemotherapy predicted failure to undergo surgery. Furthermore, African American race was associated with delayed chemotherapy. Chemotherapy was also delayed in patients on Medicare or other government insurance. Longer time to neoadjuvant chemotherapy is a modifiable risk factor that should be closely observed in multimodal cancer treatment.
引用
收藏
页码:535 / 539
页数:5
相关论文
共 26 条
[1]  
Advanced Bladder Cancer ( ABC), 2005, EUR UROL, V48, P202, DOI DOI 10.1016/J.EURUR0.2005.04.006
[2]  
Agency for Healthcare Research and Quality, DISP HEALTHC QUAL RA
[3]  
[Anonymous], 1999, Lancet, V354, P533
[4]  
[Anonymous], 2014, INT SCH RES NOTICES
[5]  
[Anonymous], HLTH COV RAC ETHN PO
[6]   The National Cancer Data Base: A powerful initiative to improve cancer care in the United States [J].
Bilimoria, Karl Y. ;
Stewart, Andrew K. ;
Winchester, David P. ;
Ko, Clifford Y. .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (03) :683-690
[7]   Racial and Ethnic Disparities in Health Care Access and Utilization Under the Affordable Care Act [J].
Chen, Jie ;
Vargas-Bustamante, Arturo ;
Mortensen, Karoline ;
Ortega, Alexander N. .
MEDICAL CARE, 2016, 54 (02) :140-146
[8]   Mortality Increases When Radical Cystectomy Is Delayed More Than 12 Weeks Results From a Surveillance, Epidemiology, and End Results-Medicare Analysis [J].
Gore, John L. ;
Lai, Julie ;
Setodji, Claude M. ;
Litwin, Mark S. ;
Saigal, Christopher S. .
CANCER, 2009, 115 (05) :988-996
[9]  
Grossman HB, 2003, NEW ENGL J MED, V349, P1880
[10]   Outcome of patients who refuse cystectomy after receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer [J].
Herr, Harry W. .
EUROPEAN UROLOGY, 2008, 54 (01) :126-132